Centro Medicina Dell'Invecchiamento, Università Cattolica Sacro Cuore, Policlinico A. Gemelli, L.go Francesco Vito 1, 00168 Rome, Italy.
Geriatrics, Italian National Research Center on Aging (INRCA), Ancona, Italy.
Age Ageing. 2014 Nov;43(6):767-73. doi: 10.1093/ageing/afu029. Epub 2014 Mar 17.
Beers criteria and screening tool of older person's prescriptions (STOPP) criteria are widely used to assess potentially inappropriate drug use (PIDU).
the aims of the present study are (i) to assess the prevalence of PIDU based on 2012 Beers criteria and STOPP criteria and (ii) to determine the impact of PIDU, as defined by these criteria, on health outcomes among older in-hospital patients.
prospective observational study.
a total of 871 in-hospital patients participating to the CRIteria to Assess Appropriate Medication Use among Elderly Complex Patients project.
outcome measures were (i) adverse drug reactions (ADR); (ii) decline in functional status; (iii) combined outcome (ADR or declined in functional status).
the prevalence of PIDU was 58.4% applying Beers criteria, 50.4% applying STOPP criteria and 75.0% combining both sets of criteria. PIDU defined based on STOPP criteria was significantly associated with ADR [odds ratio (OR) 2.36; 95% confidence interval (CI) 1.10-5.06], and decline in physical function (OR: 2.00; 95% CI: 1.10-3.64), while, despite a positive trend, no significant association was observed for Beers criteria or the combination of both criteria. The combined outcome was significantly associated with PIDU defined based on Beers (OR: 1.74; 95% CI: 1.06-2.85), STOPP criteria (OR: 2.14; 95% CI: 1.32-3.47) or both (OR 2.02; 95% CI: 1.06-3.84).
PIDU is common in hospitalised older adults and the combination of Beers and STOPP criteria might lead to the identification of a larger number of cases of PIDU than the application of a single set of criteria. STOPP criteria significantly predict all in-hospital outcomes considered, while Beers criteria were significantly associated with the combined outcome only.
Beers 标准和老年人处方筛选工具(STOPP)标准被广泛用于评估潜在不适当的药物使用(PIDU)。
本研究的目的是(i)根据 2012 年 Beers 标准和 STOPP 标准评估 PIDU 的患病率,以及(ii)确定这些标准定义的 PIDU 对住院老年患者健康结果的影响。
前瞻性观察性研究。
共有 871 名参与“评估老年复杂患者适当用药标准”项目的住院患者。
观察指标为(i)药物不良反应(ADR);(ii)功能状态下降;(iii)联合结局(ADR 或功能状态下降)。
应用 Beers 标准 PIDU 的患病率为 58.4%,应用 STOPP 标准为 50.4%,联合应用两套标准为 75.0%。基于 STOPP 标准的 PIDU 与 ADR[比值比(OR)2.36;95%置信区间(CI)1.10-5.06]和身体功能下降显著相关(OR:2.00;95% CI:1.10-3.64),而 Beers 标准或两套标准的组合则没有观察到显著相关性。联合结局与基于 Beers(OR:1.74;95% CI:1.06-2.85)、STOPP 标准(OR:2.14;95% CI:1.32-3.47)或两者(OR 2.02;95% CI:1.06-3.84)的 PIDU 显著相关。
PIDU 在住院老年患者中很常见,Beers 和 STOPP 标准的联合应用可能会比单一标准的应用识别出更多的 PIDU 病例。STOPP 标准显著预测了所有考虑的住院结局,而 Beers 标准仅与联合结局显著相关。